The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 30, 2025
Filed:
May. 06, 2024
Applicant:
Lava Therapeutics N.v., Utrecht, NL;
Inventors:
Robertus Cornelis Roovers, Utrecht, NL;
Johannes Jelle Van Der Vliet, Amsterdam, NL;
Lisa Anna King, Amsterdam, NL;
Paul Willem Henri Ida Parren, Utrecht, NL;
Victoria Iglesias Guimarais, Utrecht, NL;
David Lutje Hulsik, Utrecht, NL;
Peter Alexander Gerardus Maria Machielsen, Utrecht, NL;
Assignee:
LAVA THERAPEUTICS N.V., Utrecht, NL;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C07K 16/46 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3069 (2013.01); A61K 39/001195 (2018.08); A61P 35/00 (2018.01); C07K 16/2809 (2013.01); C07K 16/468 (2013.01); C07K 2317/31 (2013.01); C07K 2317/526 (2013.01); C07K 2317/565 (2013.01);
Abstract
The present invention relates to antibodies capable of binding human PSMA and capable of binding a human Vγ9Vδ2 T cell receptor. The invention further relates to pharmaceutical compositions comprising the antibodies of the invention and to uses of the antibodies of the invention for medical treatment.